MICs of 14 antimicrobial agents for 29 strains of Edwardsiella tarda were determined by an agar dilution method. Of the agents tested, ciprofloxacin, enoxacin, and norfloxacin were the most active on a weight basis. All strains were also susceptible to clinically achievable concentrations of ampicillin, chloramphenicol, tetracycline, trimethoprim, sulfamethoxazole, trimethoprim plus sulfamethoxazole, cefotaxime, and gentamicin. Ninety percent of the strains demonstrated high-level resistance to polymyxin B and colistin.
Edwardsiella tarda is a member of the family Enterobacteriaceae. It has been frequently isolated from cold-blooded animals, particularly aquatic animals and from natural aquatic habitats (4, 13) ; it is an uncommon pathogen in humans. The majority of strains isolated from humans have been from the feces of patients with diarrhea (6, 7, 10) . E. tarda has also been isolated from patients with bacteremia, endocarditis, meningitis, hepatobiliary infection, urinary tract infection, and skin and soft tissue infections (2) (3) (4) Results of susceptibility testing are shown in Table 1 . All isolates were quite susceptible to the agents tested, except polymyxin B and colistin. In addition, all the isolates produced beta-lactamase; given the low MICs of ampicillin and cefotaxime for E. tarda, the clinical relevance of this finding is not clear. The most active agents on a weight basis were ciprofloxacin, enoxacin, norfloxacin, and cefotaxime. All of our isolates were susceptible to SMX, although occasional resistance to sulfonamides has been reported (4). Ten percent of strains were susceptible to polymyxin B and colistin; the remaining 90% demonstrated high-level resistance, similar to previous reports (9) .
New oxyquinolones such as ciprofloxacin, enoxacin, and norfloxacin have been shown to have excellent in vitro activity against many enteric pathogens (1, 5, 12).
Our data indicate that a variety of different antimicrobial agents might be effective for therapy of both enteric and pyogenic infections involving E. tarda. In addition, these data indicate the potential usefulness of a polymyxin-containing medium for selective isolation of E. tarda from feces of subjects with diarrhea.
